GlassScriptPhysician profile
Stuart J Sabol
NPI 1972579712
$677.12
in general payments reported to CMS, 2019-2025
16 companies · $61.32 in 2025
The $61.32 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $69.28 · 2021: $55.94 · 2022: $67.67 · 2023: $34.99 · 2024: $84.85 · 2025: $61.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157 · Debt Forgiveness: $23.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.30 |
| Debt Forgiveness | $23.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $107.20 | 2019 | |
| Smith+Nephew, INC. | $98.83 | 2019-2021 | |
| Genzyme Corporation | $84.52 | 2019-2025 | |
| Glaxosmithkline, LLC. | $61.91 | 2024 | Nucala |
| Intersect Ent, INC. | $52.53 | 2019 | |
| Optinose US, INC. | $48.20 | 2022-2025 | |
| Kaleo, INC. | $37.22 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $28.98 | 2019-2023 | Airsupra |
| Regeneron Healthcare Solutions, INC. | $27.02 | 2022 | |
| Stryker Corporation | $24.57 | 2019-2020 | |
| Karl Storz Endoscopy-America | $23.86 | 2025 | |
| Idorsia Pharmaceuticals US INC | $17.66 | 2023 | Quviviq |
| Arbor Pharmaceuticals, INC. | $16.72 | 2020 | |
| Alk-Abello, INC | $16.32 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.11 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Sabol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.